BONESUPPORT HOLDING AB (BOEUF)
23.49
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
BONESUPPORT EPS Diluted (Quarterly) : 0.1309 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1309 |
| March 31, 2026 | 0.0875 |
| December 31, 2025 | 0.0703 |
| September 30, 2025 | 0.0543 |
| June 30, 2025 | 0.0823 |
| March 31, 2025 | 0.0146 |
| December 31, 2024 | 0.0748 |
| September 30, 2024 | 0.0439 |
| June 30, 2024 | 0.0385 |
| March 31, 2024 | 0.0316 |
| December 31, 2023 | 0.0152 |
| September 30, 2023 | 0.3212 |
| June 30, 2023 | 0.0075 |
| March 31, 2023 | 0.0005 |
| December 31, 2022 | -0.0297 |
| September 30, 2022 | -0.022 |
| June 30, 2022 | -0.0257 |
| March 31, 2022 | -0.0272 |
| December 31, 2021 | -0.0426 |
| September 30, 2021 | -0.0254 |
| June 30, 2021 | -0.0503 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.0377 |
| December 31, 2020 | -0.0495 |
| September 30, 2020 | -0.0377 |
| June 30, 2020 | -0.0421 |
| March 31, 2020 | -0.058 |
| December 31, 2019 | -0.0817 |
| September 30, 2019 | -0.0667 |
| June 30, 2019 | -0.098 |
| March 31, 2019 | -0.0822 |
| December 31, 2018 | -0.0976 |
| September 30, 2018 | -0.1293 |
| June 30, 2018 | -0.0864 |
| March 31, 2018 | -0.0823 |
| December 31, 2017 | -0.1234 |
| September 30, 2017 | -0.0576 |
| June 30, 2017 | -0.0887 |
| March 31, 2017 | -0.0714 |
| December 31, 2016 | -0.0784 |
| September 30, 2016 | -0.0837 |
| June 30, 2016 | -0.058 |
| March 31, 2016 | -0.0422 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioInvent International AB | -0.1982 |
| Hansa Biopharma AB | -0.279 |
| BioArctic AB | 0.2615 |
| Swedish Orphan Biovitrum AB | 0.1673 |
| Diamyd Medical AB | -0.0909 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 8.743M |
| Revenue (Quarterly) | 37.99M |
| Total Expenses (Quarterly) | 29.24M |
| Enterprise Value | 1.494B |
| Gross Profit Margin (Quarterly) | 90.81% |
| Profit Margin (Quarterly) | 23.02% |
| Earnings Yield | 1.46% |
| Operating Earnings Yield | 2.10% |
| Normalized Earnings Yield | 1.439 |